Exlservice Hldgs Stock Price, News & Analysis

EXL (NASDAQ: EXLS) has been recognized as a leader in all six categories of the NelsonHall 2021 Life, Annuities, and Pension Operations Transformation Report. The company is celebrated for its advanced digital solutions that utilize artificial intelligence and natural language processing, enhancing operational efficiency in the insurance sector. EXL's innovations support digital transformation, straight-through processing capabilities, and real-time analytics. This acknowledgment highlights EXL's commitment to improving customer experiences and operational capabilities within the life and pension markets.

EXL Announces Acquisition of Clairvoyant

EXL (NASDAQ: EXLS) has acquired Clairvoyant, enhancing its data-driven strategy with additional capabilities in data engineering and cloud services. This acquisition aims to bolster EXL’s analytics business, offering clients improved decision-making and digital transformation solutions. Clairvoyant, founded in 2012 and recognized for its rapid growth, will contribute its expertise to enhance EXL’s offerings in industries such as insurance, healthcare, and banking. The transaction is expected to positively impact EXL's adjusted diluted EPS in 2022.

ExlService Holdings, Inc. (NASDAQ: EXLS) announced that Garen Staglin will not seek re-election at the Annual Meeting in June 2022. Vikram Pandit has been appointed Chairman of the Board, effective January 1, 2022. Garen will remain a director and serve on the Compensation and Nominating Committees until the meeting. Rohit Kapoor, CEO, praised Garen's contributions while expressing confidence in Vikram's leadership. Staglin highlighted the company's growth during his tenure and expressed faith in EXL's future under Pandit's guidance.

EXL Recognized as a Leader in Healthcare Analytics

On December 15, 2021, EXL (NASDAQ: EXLS) announced its recognition as a Leader in the Everest Group's Healthcare Analytics Services PEAK Matrix® Assessment 2022. The report commended EXL for its comprehensive healthcare analytics solutions, including EXL Data Management and EXLClarity™, which enhance value-based strategies through advanced analytics. EXL's strong partnerships and client relationships were highlighted as key strengths contributing to its leadership status, along with its significant investments in innovation and service delivery.

EXLClarity™ Earns High Customer Satisfaction Scores

On November 8, 2021, EXL (NASDAQ: EXLS) announced that its EXLClarity™ platform was recognized as a leader in the 2021 Risk Adjustment & Analytics KLAS Performance Report. Customers rated the platform with an overall score of 93.6 and an “A” for customer experience, with 100% indicating they would purchase it again. The platform aids healthcare payers and providers in enhancing value-based strategies by delivering comprehensive patient risk data and analytics, enabling improved compliance and outcomes.

ExlService Holdings (NASDAQ: EXLS) reported Q3 2021 revenues of $290.3 million, a 20.5% increase year-over-year. Diluted earnings per share (GAAP) rose to $0.77 from $0.76 in Q3 2020, while adjusted diluted EPS (Non-GAAP) increased to $1.30, up 25.0% from the prior year. The company expanded its client base by adding 40 new clients in 2021, reflecting growth driven by analytics and AI initiatives. Revenue guidance for the full year is adjusted to between $1.11 billion and $1.12 billion, a 15% to 16% increase compared to 2020.

ExlService Holdings (NASDAQ: EXLS) has announced a new $300 million stock repurchase program effective January 1, 2022, replacing the previous $200 million plan set in December 2019, which has seen approximately $162 million repurchased by September 30, 2021. The new program enables the company to buy shares on the open market and through private transactions as deemed appropriate by management, while ensuring compliance with securities regulations. This initiative aims to enhance shareholder value and manage excess capital, providing flexibility in share repurchase timing and volume.